Training tomorrow's healthcare professionals
Nearly three dozen pre-nursing students will soon gain hands-on experience alongside healthcare professionals in a hospital setting through an internship provided by Taft College.
Stay updated with breaking news from Ken Keller. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nearly three dozen pre-nursing students will soon gain hands-on experience alongside healthcare professionals in a hospital setting through an internship provided by Taft College.
AstraZeneca plc and Daiichi Sankyo's Enhertu has gained US approval for treating HER2-positive solid tumours, marking a significant advancement in cancer treatment.
On Friday, the FDA approved Daiichi Sankyo Ltd’s (OTC:DSKYF) (OTC:DSNKY) and AstraZeneca Plc’s (NASDAQ:AZN) Enhertu (fam-trastuzumab deruxtecan-nxki) for unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior systemic treatment and have no satisfactory alternative treatment options. This indication is approved under accelerated approval based on objective response rate (ORR) and duration of response (DOR). Continued approval for this indicat
Press Release ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2...
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Apr 5, 2024--